ERVW-1 and myeloid sarcoma: As the MSRV/HERV-Wenv expression has been shown to be higher in MS patients compared to healthy controls [34, 35], the reduced expression of MSRV/HERV-W in vitro indicates a potential mechanism of action of antiretroviral medications in MS.